Clinical Trial Update: Adherence in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04281)(COMPLETED)

View source ↗

Summary

This completed clinical trial update describes adherence to PegIntron (peginterferon alfa-2b) and Rebetol (ribavirin) in hepatitis C patients enrolled in a pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• PegIntron (pegylated interferon alfa-2b)
• Rebetol (ribavirin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C, Chronic, Hepacivirus | Status: COMPLETED | Results posted: 2010-05-17